Ed Sci Monit, 2012; 18(four): CR2154 44. Wintergerst ES, Maggini S, Hornig DH: Immune-enhancing

Ed Sci Monit, 2012; 18(four): CR2154 44. Wintergerst ES, Maggini S, Hornig DH: Immune-enhancing function of vitamin C and zinc and effect on clinical conditions. Ann Nutr Metab, 2006; 50: 854 45. Wintergerst ES, Maggini S, Hornig DH: Immune-enhancing function of vitamin C and zinc and impact on clinical conditions. Ann Nutr Metab, 2006; 50: 854 46. Gerber WF: Effect of ascorbic acid, sodium salicylate and caffeine on the serum interferon level in response to viral infection. Pharmacology, 1975; 13: 2283 47. Karpinska T, Kawecki Z, Kandefer-Szerszen M: The influence of ultraviolet irradiation, L-ascorbic acid and calcium chloride around the induction of interferon in human embryo fibroblasts. Arch Immunol Ther Exp (Warsz), 1982; 30: 3348. Mandl J, Szarka A, Banhegyi G: Vitamin C: update on physiology and pharmacology. Br J Pharmacol, 2009; 157(7): 109710 49. Mikirova NA, Casciari JJ, Taylor PR, Taylor P: Impact of high-dose intravenous vitamin C on inflammation in cancer patients. J Transl Med, 2012; ten: 189 50. Mikirova NA, Rogers AM, Casciari JJ, Taylor P: Impact of high dose intravenous ascorbic acid on the amount of inflammation in individuals with rheumatoid arthritis. Modern Res Infl, 2012; 1(two): 262 51. Furuya A, Uozaki M, Yamasaki H et al: Antiviral effects of ascorbic acid and dehydroascorbic acids in vitro. Int J Mol Med, 2008; 22: 5415 52. White LA, Freeman CY, Forrester BD, Chappell WA: In vitro effect of ascorbic acid on infectivity of herpeviruses and paramyxoviruses. J Clin Microbiol, 1986; 24(4): 5271 53. Murata A, Oyadomari R, Ohashi T, Kitagawa K: Mechanism of inactivation of bacteriophage deltaA containing single-stranded DNA by ascorbic acid. J Nutr Sci Vitaminol (Tokyo), 1975; 21: 2619 54. Bissell MJ, Hatie C, Farson DA et al: Ascorbic acid inhibits replication and infectivity of avian RNA tumor virus. Cell Biol, 1980; 77(five): 27115 55. Johannsen EC, Schooley RT, Kaye KM: Epstein-Barr virus (infectious mononucleosis). In: Mandell GL, Bennett JE, Dolin R (eds.), Principles and Practive of Infectious Illnesses. 6th ed. vol two. Philadelphia (PA): Churchill Livingstone, 2005; 18011 56. Torre D, Tambini R: Acyclovir for treatment of infectious mononucleosis: a meta-analysis. Scand J Infect Dis, 1999; 31: 5437 57. Tynell E, Aurelius E, Brandell A et al: Acyclovir and prednisolone therapy of acute infectious mononucleosis: a multicenter, double-blind, placebocontrolled study. J Infect Dis, 1996; 174(two): 3241 58.Ixazomib citrate Yongjun Y, Maguire TG, Alwine JC: Human cytomegalovirus activates glucose transporter 4 expression to enhance glucose update in the course of infection.Flubendazole J Virol, 2011; 85(four): 15730 59. Rose RC: Transport of ascorbic acid and also other water-soluble vitamins.PMID:25147652 Biochim Biophys Acta, 1988; 947(two): 3356 60. Vera JC, Rivas CI, Fischbarg J, Golde DW: Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid. Nature, 1993; 364: 792 61. Vera JC, Rivas CI, Velasquez FV et al: Resolution of your facilitated transport of dehydroascorbic acid from its intracellular accumulation as ascorbic acid. J Biol Chem, 1995; 270(40): 237062 62. Gunville CF, Mourani PM, Ginde AA: The Part of Vitamin D in Prevention and Therapy of Infection. Inflamm Allergy Drug Targets, 2013; 12(4): 2395 63. Cantorna MT, Yu S, Bruce D: The paradoxical effects of vitamin D on form 1 mediated immunity. Mol Elements Med, 2008; 29: 3695 64. Beardb JA, Beardena A, Strikera R: Vitamin D plus the anti-viral state. J Clin Virol, 2011; 50(3): 194This perform is licensed u.